Qtron Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
6,611
-5,322
-45% -$289K 0.04% 425
2026
Q1
$749K Sell
11,933
-5,400
-31% -$432K 0.1% 256
2025
Q4
$1.65M Sell
17,333
-416
-2% -$40.8K 0.21% 95
2025
Q3
$1.73M Hold
17,749
0.21% 96
2025
Q2
$1.91M Hold
17,749
0.24% 87
2025
Q1
$1.79M Sell
17,749
-705
-4% -$71K 0.27% 79
2024
Q4
$1.65M Sell
18,454
-2,983
-14% -$263K 0.23% 85
2024
Q3
$1.8M Hold
21,437
0.25% 84
2024
Q2
$1.65M Buy
21,437
+6,429
+43% +$471K 0.24% 83
2024
Q1
$1.03M Hold
15,008
0.15% 180
2023
Q4
$868K Sell
15,008
-2,799
-16% -$149K 0.14% 187
2023
Q3
$940K Buy
17,807
+8,621
+94% +$452K 0.18% 139
2023
Q2
$497K Hold
9,186
0.09% 278
2023
Q1
$460K Buy
9,186
+1,555
+20% +$73.3K 0.09% 287
2022
Q4
$353K Hold
7,631
0.07% 314
2022
Q3
$296K Hold
7,631
0.07% 336
2022
Q2
$284K Buy
+7,631
New +$311K 0.06% 341
2020
Q4
Sell
-9,505
Closed -$363K 330
2020
Q3
$363K Buy
+9,505
New +$366K 0.13% 197

Other funds holding BSX

Qtron Investments's BSX Position: Q2 2026 in Review

Qtron Investments reduced its Boston Scientific (BSX) stake by 45% in Q2 2026, selling an estimated $289K and leaving 6,611 shares worth $282K. The position accounts for 0.04% of the portfolio, ranked #425.

Qtron Investments first reported a position in BSX in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.91M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Qtron Investments held 6,611 shares of Boston Scientific worth $282K as of Q2 2026.
  • Qtron Investments sold 5,322 Boston Scientific shares in Q2 2026, an estimated $289K.
  • Boston Scientific made up 0.04% of Qtron Investments's portfolio in Q2 2026, its #425 holding.
  • Qtron Investments first reported a position in Boston Scientific in Q3 2020 and has held it in 18 quarters since.
  • Qtron Investments's Boston Scientific position peaked at $1.91M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.